The Effect of PAP on ISSHL Comorbided With OSA

• Status: Recruiting
• Trial end date: 2029-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This clinical randomized controlled study is to explore the effect of positive airway pressure(PAP) on patients in Beijing Tsinghua Changgung Hospital diagnosed with both idiopathic sudden sensorineural hearing loss comorbided(ISSHL) and obstructive sleep apnea(OSA) between Dec. 2019 to Dec. 2029.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Beijing Tsinghua Chang Gung Hospital
• Treatments: Methylprednisolone; Methylprednisolone Acetate; Methylprednisolone Hemisuccinate; Prednisolone; Prednisolone acetate; Prednisolone hemisuccinate; Prednisolone phosphate

Criteria

Inclusion Criteria:

1. aged >= 18 and <= 70,

2. diagnosed with OSA by full-night in-lab or home-stay PSG according to AASM 2012 criteria, and AHI > 15/h,

3. diagnosed with ISSHL by AAO-HNS 2019 criteria,

4. ISSHL onset within 1 week.

Exclusion Criteria:

1. sudden hearing loss with certain causes,

2. with severe comorbid diseases,

3. pregnant or breast-feeding women,

4. AHI <= 15/h,

5. hearing threshold recovered > 50% when included,

6. previously regularly treated with PAP.